| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/09/2011 | CN101967192A Fusion protein of anti-CD20 antibody fragment and lidamycin (LDM) as well as preparation method and application thereof |
| 02/09/2011 | CN101967187A Protein related to cell stress, and coding gene and application thereof |
| 02/09/2011 | CN101967183A Artificially synthesized novel antithrombotic peptide derivative, preparation method and application thereof |
| 02/09/2011 | CN101967182A Antimicrobial compound and preparation method and application thereof |
| 02/09/2011 | CN101967026A Energy-saving emission-reduction seawater comprehensive utilizing method |
| 02/09/2011 | CN101966337A Genetic products differentially expressed in tumors and the use thereof |
| 02/09/2011 | CN101966334A Application of lecithin superoxide dismutase composite in preparation of medicines for treating and/or preventing cardiac ischemic injury |
| 02/09/2011 | CN101966333A Prebiotic liquid compound preparation capable of preventing or relieving constipation in pregnant women |
| 02/09/2011 | CN101966332A Application of gap junction protein and coding gene thereof in preparing medicament for reversing malignant phenotype of cancer stem cell |
| 02/09/2011 | CN101966171A Hydrosoluble reduced enzyme Q10 composition and preparation method thereof |
| 02/09/2011 | CN101966162A Insulin buccal tablets and preparation method thereof |
| 02/09/2011 | CN101647773B Octreotide acetate injection |
| 02/09/2011 | CN101422602B Function food capable of improving the women cimacteric symptom |
| 02/09/2011 | CN101411879B SiO2/Au nano material with nucleocapsid structure-biological protein medicament complex and preparation method thereof |
| 02/09/2011 | CN101352573B Recombinant human granulocyte colony stimulating factor lysine defect body modified by polyethyleneglycol |
| 02/09/2011 | CN101289494B Cyclic peptides with vasodilator action, preparation and uses thereof |
| 02/09/2011 | CN101280021B Engineered protein VP28-C against shrimp white spot syndrome virus, preparation and use thereof |
| 02/09/2011 | CN101134953B Recombinant human pancreas kininogenase |
| 02/09/2011 | CN101134952B Human urine kininogenase and method for making same |
| 02/09/2011 | CN101073596B Alpha-glycosidase inhibitor, its extraction and use |
| 02/09/2011 | CN101048171B Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds |
| 02/09/2011 | CN101020044B Regulating and controlling effect of thymine DNA glycosylase on signal transducing path |
| 02/08/2011 | US7884199 HCV NS3-NS4 protease resistance mutants |
| 02/08/2011 | US7884198 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 02/08/2011 | US7884189 Carboxyltransferase domain of acetyl-CoA carboxylase |
| 02/08/2011 | US7884188 polypeptide obtained from a haematophagous arthropod that inhibits the classical complement pathway and the alternative complement pathway by inhibiting cleavage of C5 by classical and alternative C5 convertases |
| 02/08/2011 | US7884186 Isotopically labeled trapping agent and method for identifying reactive metabolites |
| 02/08/2011 | US7884185 Hydrogels and uses thereof |
| 02/08/2011 | US7884184 comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region; suppressing an antigen-specific immune response to a target antigen; Autoimmune disease |
| 02/08/2011 | US7884183 Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
| 02/08/2011 | US7884182 Chemical peptide ligation with three or more components |
| 02/08/2011 | US7884181 Pharmaceutical formulation comprising crystalline insulin and dissolved insulin |
| 02/08/2011 | US7884180 binds formyl peptide receptor-like 1 (FPRL1); useful for treating disorders associated with G-protein coupled receptor activation |
| 02/08/2011 | US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 02/08/2011 | US7884178 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 02/08/2011 | US7884084 Oligonucleotide seqences for controlling expression of leptin receptor gene associated protein (OB-RGRP); for treatment and prevention of bone, thrombic, sexual, blood, immunological, inflammatory and cancer disorders |
| 02/08/2011 | US7884083 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 02/08/2011 | US7884082 Combined therapeutical treatment of hyperproliferative diseases |
| 02/08/2011 | US7884078 CPG15 compounds as insulin receptor and insulin-like growth factor receptor agonists |
| 02/08/2011 | US7884076 Multipeptide regimen for the treatment of autistic spectrum, behavioral, emotional and visceral inflammation/autoimmune disorders |
| 02/08/2011 | US7884075 such as polyethylene glycol or polysialic acid; prolonging in vivo-half-life in blood |
| 02/08/2011 | US7884074 Compounds and methods for prevention and/or treatment of inflammation using the same |
| 02/08/2011 | US7884073 Modified growth hormone |
| 02/08/2011 | US7884072 produce more stem cells in vivo or in vitro by culture, for transplantation into patient; increase neurogenesis or new olfactory neuron numbers; stroke, neurodegenerative disease of Alzheimer's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and Parkinson's disease |
| 02/08/2011 | US7884071 Gels containing luteinizing hormone releasing hormone antagonist (ozarelix) in lyophilized form, aqueous solution of sodium chloride; colloids; for treating hormone related disorders, prostate cancer, breat cancer, uterine myomas, endometriosis, puberty disorders, and reproductive disorders |
| 02/08/2011 | US7884070 for treating Cryptococcus infection in humans, animals, and plants |
| 02/08/2011 | US7884069 Administering hematopoietic factor; Granulocyte-colony stimulating factor, granulocyte- macrophage CSF (GM-CSF), interleukin-3 (IL-3), and IL-5; neuralogical conditions, ischemia or hypoxia, depression |
| 02/08/2011 | US7884068 Prevent mammals tissue injuries |
| 02/08/2011 | US7884067 Peptides derived from cadherin and methods of use thereof |
| 02/08/2011 | US7884066 Increasing concentration of neural epidermal growth factor-like 1 (NELL-1) gene product in osteogenic cells; bone grafts; osteoporosis, fracture repair |
| 02/08/2011 | US7883896 for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as lung adenocarcinoma, lung carcinoma |
| 02/08/2011 | US7883888 Replication incompetent Adenovirus (AdV) vectors, selectively killing cancer cells |
| 02/08/2011 | US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/08/2011 | US7883880 DNA polymerase lambda and uses thereof |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883718 Methods and devices for the sustained release of multiple drugs |
| 02/08/2011 | US7883715 Pesticide compositions containing dicarboxylic acids |
| 02/08/2011 | US7883708 Substance derived from basidiomycetes culture, method for producing it and its use |
| 02/08/2011 | US7883707 Induction of antigen specific immunnologic tolerance |
| 02/08/2011 | US7883706 Methods for using Streptococcus pyogenes polypeptides |
| 02/08/2011 | US7883704 Methods for inhibiting the activity of the P40 subunit of human IL-12 |
| 02/08/2011 | US7883699 Methods for enlarging the lumen of an obstructed biological conduit |
| 02/08/2011 | US7883695 IL-12P40 and IL-B30 polypeptide complex |
| 02/08/2011 | US7883541 Muscle-based grafts/implants |
| 02/08/2011 | US7883032 Devices and formulations |
| 02/08/2011 | CA2639651C Orally administered peptides to ameliorate atherosclerosis |
| 02/08/2011 | CA2529124C Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 02/08/2011 | CA2494300C Growth hormone releasing peptides |
| 02/08/2011 | CA2431461C 1,5 benzothiazepines and their use as antihyperlipidemics |
| 02/08/2011 | CA2419822C Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 02/08/2011 | CA2409854C Sustained release pharmaceutical compositions for the parenteral administration of biologically active hydrophilic compounds |
| 02/08/2011 | CA2314186C Adjuvanted vaccine comprising a cpg oligonucleotide and an antigen from streptococcus pneumoniae |
| 02/08/2011 | CA2296797C Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/08/2011 | CA2275525C Gel composition and methods |
| 02/08/2011 | CA2273825C Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 02/08/2011 | CA2272240C Reductive alkylation of glycopeptide antibiotics |
| 02/08/2011 | CA2258097C Insulin preparations containing nacl |
| 02/08/2011 | CA2223407C Oxidant scavengers |
| 02/08/2011 | CA2220871C Peptide/protein suspending formulations |
| 02/08/2011 | CA2220830C Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 02/08/2011 | CA2217967C Augmentation in serca2 mediated calcium ion transport for regulation of cardiac muscle contractility |
| 02/08/2011 | CA2210467C Osteoprotegerin |
| 02/08/2011 | CA2199940C Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/08/2011 | CA2164226C Methods for selectively stimulating proliferation of t cells |
| 02/03/2011 | WO2011014890A1 Modified factor ix polypeptides and uses thereof |
| 02/03/2011 | WO2011014883A2 Skin rejuvenation and wrinkle treatment by gingival fibroblast and its growth factor: activation of effect by hyluronic acid |
| 02/03/2011 | WO2011014882A1 CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-α TO HEPATITIS C INFECTED PATIENTS |
| 02/03/2011 | WO2011014872A2 Compositions and methods for diagnosing, treating or preventing neoplasias |
| 02/03/2011 | WO2011014807A1 Methods and compositions for promoting regeneration by increasing intracellular sodium concentration |
| 02/03/2011 | WO2011014771A1 Monophosphorylated lipid a derivatives |
| 02/03/2011 | WO2011014707A2 Therapeutic agents for reducing parathyroid hormone levels |
| 02/03/2011 | WO2011014693A2 Bacteriophages expressing amyloid peptides and uses thereof |
| 02/03/2011 | WO2011014680A2 Gastric inhibitory peptide variants and their uses |
| 02/03/2011 | WO2011014671A1 Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods |
| 02/03/2011 | WO2011014487A1 Hepatitis c virus ns3 protease inhibitors |
| 02/03/2011 | WO2011013912A2 Pharmaceutical composition for enhancing radiation therapy for cancer, and method for screening active material for enhancing radiation therapy for cancer |
| 02/03/2011 | WO2011013728A1 Motilin-like peptide compound having transmucosal absorbability imparted thereto |
| 02/03/2011 | WO2011013703A1 Pancreatic endocrine cell indicator and utilization of same |
| 02/03/2011 | WO2011013700A1 Carrier peptide fragment and use thereof |